Tandem Diabetes Care, Inc.
TNDM
$19.16
$0.985.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.74% | 10.75% | 0.72% | -3.11% | -6.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.74% | 10.75% | 0.72% | -3.11% | -6.68% |
| Cost of Revenue | 18.58% | 12.43% | 5.11% | 0.17% | -2.11% |
| Gross Profit | 33.15% | 9.10% | -3.48% | -6.26% | -10.97% |
| SG&A Expenses | 14.48% | 10.03% | 2.57% | 0.29% | 5.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.75% | 12.24% | 5.78% | 3.11% | 4.65% |
| Operating Income | 30.43% | -22.61% | -47.64% | -62.49% | -188.37% |
| Income Before Tax | 58.29% | 39.92% | 40.76% | 31.90% | -137.21% |
| Income Tax Expenses | 76.28% | 5.35% | 85.50% | 40.05% | 35.30% |
| Earnings from Continuing Operations | 56.86% | 39.18% | 39.19% | 30.58% | -135.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.86% | 39.18% | 39.19% | 30.58% | -135.33% |
| EBIT | 30.43% | -22.61% | -47.64% | -62.49% | -188.37% |
| EBITDA | 34.90% | -25.13% | -54.65% | -71.97% | -261.37% |
| EPS Basic | 57.18% | 39.76% | 39.84% | 31.36% | -133.13% |
| Normalized Basic EPS | 33.44% | -21.33% | -50.86% | -56.05% | -158.68% |
| EPS Diluted | 57.18% | 39.76% | 39.84% | 31.47% | -132.34% |
| Normalized Diluted EPS | 33.43% | -21.33% | -50.86% | -56.05% | -158.68% |
| Average Basic Shares Outstanding | 0.74% | 0.91% | 1.09% | 1.32% | 1.28% |
| Average Diluted Shares Outstanding | 0.83% | 0.91% | 1.09% | 1.32% | 1.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
